MedTrace Logo

β-cell Function in Type 1 Diabetes May Not Be As Low As Presumed

NCT02199470 · Status: COMPLETED · Type: OBSERVATIONAL · Enrollment: 135

Last updated 2016-09-05

No results posted yet for this study

Summary

Enhancing endogenous insulin production in type 1 diabetic patients (T1DP) can improve glycemic control and decrease complications and rates of mortality. However, it can be succesfull even if sufficient β-cell function is present. We aimed to evaluate the extent of β-cell function by determining fasting levels of C-peptide and those after meal stimulus.

Conditions

Sponsors & Collaborators

  • Gonca Incemehmet Tamer

    lead OTHER

Principal Investigators

  • Gonca Incemehmet Tamer, I · Istanbul Medeniyet University

Eligibility

Min Age
18 Years
Max Age
70 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2013-04-30
Primary Completion
2014-07-31
Completion
2015-03-31

Countries

  • Turkey (Türkiye)

Study Locations

More Related Trials

Entities

Diseases

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT02199470 on ClinicalTrials.gov